KR20230077860A - Food for special medical comprising fatty acid complex FAC - Google Patents
Food for special medical comprising fatty acid complex FAC Download PDFInfo
- Publication number
- KR20230077860A KR20230077860A KR1020210165031A KR20210165031A KR20230077860A KR 20230077860 A KR20230077860 A KR 20230077860A KR 1020210165031 A KR1020210165031 A KR 1020210165031A KR 20210165031 A KR20210165031 A KR 20210165031A KR 20230077860 A KR20230077860 A KR 20230077860A
- Authority
- KR
- South Korea
- Prior art keywords
- fatty acid
- acid complex
- prepared
- weight
- perilla
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 120
- 239000000194 fatty acid Substances 0.000 title claims abstract description 120
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 120
- 150000004665 fatty acids Chemical class 0.000 title claims abstract description 120
- 235000013305 food Nutrition 0.000 title abstract description 6
- 244000068988 Glycine max Species 0.000 claims abstract description 38
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 38
- 235000021056 liquid food Nutrition 0.000 claims abstract description 31
- 238000004519 manufacturing process Methods 0.000 claims abstract description 23
- 238000002156 mixing Methods 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 7
- 235000004347 Perilla Nutrition 0.000 claims description 36
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 29
- 239000002131 composite material Substances 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 24
- 229920002261 Corn starch Polymers 0.000 claims description 15
- 239000008120 corn starch Substances 0.000 claims description 15
- 239000000377 silicon dioxide Substances 0.000 claims description 15
- 235000012239 silicon dioxide Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 14
- 238000000227 grinding Methods 0.000 claims description 12
- 238000005520 cutting process Methods 0.000 claims description 10
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 7
- 239000001569 carbon dioxide Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 5
- 238000000265 homogenisation Methods 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 abstract description 9
- 229940099112 cornstarch Drugs 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 7
- 229940093532 cetyl myristoleate Drugs 0.000 description 6
- DYIOQMKBBPSAFY-BENRWUELSA-N Palmityl myristoleate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCC DYIOQMKBBPSAFY-BENRWUELSA-N 0.000 description 5
- DYIOQMKBBPSAFY-UHFFFAOYSA-N palmityl myristoleate Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCC=CCCCC DYIOQMKBBPSAFY-UHFFFAOYSA-N 0.000 description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 238000003801 milling Methods 0.000 description 4
- 201000008482 osteoarthritis Diseases 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000021067 refined food Nutrition 0.000 description 4
- 239000003760 tallow Substances 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004575 Infectious Arthritis Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 230000037231 joint health Effects 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 201000001223 septic arthritis Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/26—Homogenisation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/44—Supercritical state
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 (1) 지방산 복합물에 옥수수 전분 및 이산화규소를 혼합한 후 절삭하여 지방산 복합 혼합물을 제조하는 단계; (2) 대두에 열수를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하는 단계; (3) 차조기를 초임계 추출하여 차조기 초임계 추출물을 제조하는 단계; (4) 상기 (1)단계의 제조한 지방산 복합 혼합물에 상기 (3)단계의 제조한 차조기 초임계 추출물을 첨가하여 용해시켜 지방산 복합물 용해액을 제조하는 단계; 및 (5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 혼합한 후 멸균하고 균질화하는 단계를 포함하여 제조하는 것을 특징으로 하는 지방산 복합물 액상 식품의 제조방법 및 상기 방법으로 제조된 지방산 복합물 액상 식품에 관한 것이다.The present invention comprises (1) preparing a fatty acid composite mixture by mixing corn starch and silicon dioxide with a fatty acid composite and then cutting; (2) adding hot water to soybeans, grinding them, and homogenizing them to prepare ground soybeans; (3) supercritical extraction of perilla to prepare a supercritical extract of perilla; (4) preparing a fatty acid complex solution by adding and dissolving the perilla supercritical extract prepared in step (3) to the fatty acid complex mixture prepared in step (1); and (5) mixing the ground soybean product prepared in step (2) with the fatty acid complex solution prepared in step (4) and then sterilizing and homogenizing the fatty acid complex liquid food. It relates to a manufacturing method and a fatty acid complex liquid food prepared by the method.
지방산복합물 FAC(fatty acid complex)는 우지 추출물(Beef Tallow Extract)로부터 추출한 성분으로서 CMO(Cetyl Myristoleate; cerasomal cis-9-cetylmyristoleate)라고 불리는 지방산 복합군으로, 소와 같은 동물의 연결조직에서 추출하며, 식물에서도 소량 발견된다.Fatty acid complex (FAC) is a component extracted from Beef Tallow Extract and is a complex group of fatty acids called CMO (Cetyl Myristoleate; cerasomal cis-9-cetylmyristoleate). It is extracted from connective tissue of animals such as cattle, It is also found in small amounts in plants.
1970년대 초반, 다이얼(Diel)에 의해 CMO(Cetyl Myristoleate)가 관절염에 많은 도움을 준다는 것이 발견되었다. CMO는 일반적인 관절염이나 류마티스 치료제와는 달리 손상된 면역시스템이 정상적으로 되도록 도와주어 증세가 악화되는 것을 근본적으로 막아주어 관절 및 류마티스 보조제로서 사용된다.In the early 1970s, it was discovered by Diel that CMO (Cetyl Myristoleate) was very helpful for arthritis. Unlike general arthritis or rheumatism drugs, CMO is used as an adjuvant for joints and rheumatism by helping the damaged immune system to normalize and fundamentally preventing symptoms from worsening.
일반적으로 관절이란 뼈와 뼈가 만나는 부위로써 뼈와 뼈 사이가 부드럽게 운동할 수 있도록, 연골, 관절낭, 활막, 인대, 힘줄, 근육 등으로 구성되어 있으며 움직임에 따라 발생하는 충격을 흡수하는 역할을 한다. 이러한 관절에 나타나는 염증성 질환은 류마티스, 감염성 관절염 등의 여러 원인으로 인하여 관절 연골이나 뼈에 변성이나 파괴가 일어나는 변형성 관절염, 가용성 대사산물이 관절 주변의 결합 조직 내에 결정으로 침착되는 결정성 관절염 등으로 크게 구분될 수 있다.In general, a joint is a part where bones meet, and it is composed of cartilage, joint capsule, synovial membrane, ligament, tendon, muscle, etc. so that bones can move smoothly between bones. . Inflammatory diseases of these joints are largely divided into degenerative arthritis in which degeneration or destruction of articular cartilage or bone occurs due to various causes such as rheumatoid arthritis and infectious arthritis, and crystalline arthritis in which soluble metabolites are deposited as crystals in the connective tissue around the joint. can be distinguished.
퇴행성 관절염, 즉 골관절염은 관절을 구성하는 연골세포(chondrocytes)에 노화 등의 퇴행이 발생하여, 연골세포에서 관절의 기질 물질들인 칼시토닌(calcitonin) 등의 합성이 저해됨과 동시에 LTB4, PGE2, COX-2 등의 염증성 인자가 생성됨에 따라 관절조직이 파괴됨으로써 유발되는 질병이다.In degenerative arthritis, that is, osteoarthritis, degeneration such as aging occurs in chondrocytes constituting the joint, and the synthesis of calcitonin, which is a matrix substance of the joint, is inhibited in the chondrocytes, and at the same time, LTB 4 , PGE 2 , It is a disease caused by the destruction of joint tissue as inflammatory factors such as COX-2 are produced.
또한, 관절염은 염증성 사이토카인에 의한 일산화질소의 생성과, 생성된 일산화질소에 의한 자가 증폭적인 사이토카인의 생성으로 인해 더욱 많은 MMP의 합성이 유발되어 관절기질의 분해가 촉진됨으로써 더욱 악화된다.In addition, arthritis is further aggravated by promoting the decomposition of joint matrix due to the production of nitric oxide by inflammatory cytokines and the synthesis of more MMPs due to the production of self-amplifying cytokines by the produced nitric oxide.
한국공개특허 제2001-0046562호에는 골 관절염 치료를 위한 건강식품 조성물이 개시되어 있고, 한국등록특허 제1911877호에는 생약재 추출물을 유효성분으로 포함하는 관절염 개선용 식품 조성물이 개시되어 있으나, 본 발명의 지방산복합물 FAC를 함유하는 특수의료용도 식품과는 상이하다.Korean Patent Publication No. 2001-0046562 discloses a health food composition for the treatment of osteoarthritis, and Korean Patent Registration No. 1911877 discloses a food composition for improving arthritis containing a herbal extract as an active ingredient. It is different from food for special medical use containing fatty acid complex FAC.
본 발명은 상기와 같은 요구에 의해 안출된 것으로서, 본 발명의 목적은 관절 건강에 도움을 줄 수 있다고 알려진 건강기능식품 기능성 인정 원료인 지방산복합물 FAC(Fatty Acid Complex)를 이용하여 손쉽게 음용할 수 있는 가공식품 형태로 제조하기 위해, 부재료 선정, 배합비, 가공조건 등을 최적화하여 기호도가 우수한 지방산 복합물 액상 식품의 제조방법을 제공하는 데 있다.The present invention has been made by the above needs, and an object of the present invention is to use a fatty acid complex FAC (Fatty Acid Complex), a functionally recognized raw material for health functional foods known to be helpful for joint health, that can be easily consumed In order to manufacture in the form of processed food, it is to provide a method for producing a fatty acid complex liquid food with excellent palatability by optimizing the selection of sub-materials, mixing ratio, processing conditions, etc.
상기 과제를 해결하기 위해, 본 발명은 (1) 지방산 복합물에 옥수수 전분 및 이산화규소를 혼합한 후 절삭하여 지방산 복합 혼합물을 제조하는 단계; (2) 대두에 열수를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하는 단계; (3) 차조기를 초임계 추출하여 차조기 초임계 추출물을 제조하는 단계; (4) 상기 (1)단계의 제조한 지방산 복합 혼합물에 상기 (3)단계의 제조한 차조기 초임계 추출물을 첨가하여 용해시켜 지방산 복합물 용해액을 제조하는 단계; 및 (5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 혼합한 후 멸균하고 균질화하는 단계를 포함하여 제조하는 것을 특징으로 하는 지방산 복합물 액상 식품의 제조방법을 제공한다.In order to solve the above problems, the present invention is (1) preparing a fatty acid composite mixture by cutting after mixing corn starch and silicon dioxide in a fatty acid composite; (2) adding hot water to soybeans, grinding them, and homogenizing them to prepare ground soybeans; (3) supercritical extraction of perilla to prepare a supercritical extract of perilla; (4) preparing a fatty acid complex solution by adding and dissolving the perilla supercritical extract prepared in step (3) to the fatty acid complex mixture prepared in step (1); and (5) mixing the ground soybean product prepared in step (2) with the fatty acid complex solution prepared in step (4) and then sterilizing and homogenizing the fatty acid complex liquid food. Provides a manufacturing method of.
또한, 본 발명은 상기 방법으로 제조된 지방산 복합물 액상 식품을 제공한다.In addition, the present invention provides a fatty acid complex liquid food prepared by the above method.
본 발명의 관절염 예방 효과가 있다고 알려진 지방산복합물 FAC 함유 지방산 복합물 액상 식품은 관절염 예방 용도로 섭취가 가능하고, 기호도가 증진되어 소비자들이 더욱 선호하는 식품으로 제공할 수 있다.The fatty acid complex FAC-containing liquid food containing the fatty acid complex FAC, which is known to have an anti-arthritis effect, of the present invention can be ingested for the purpose of preventing arthritis, and can be provided as a food preferred by consumers due to improved preference.
도 1은 본 발명의 지방산복합물 FAC 제조공정을 보여준다.
도 2는 본 발명의 지방산 복합물 액상 식품의 제조공정을 보여준다.Figure 1 shows the fatty acid complex FAC manufacturing process of the present invention.
Figure 2 shows the manufacturing process of the fatty acid complex liquid food of the present invention.
본 발명의 목적을 달성하기 위하여, 본 발명은In order to achieve the object of the present invention, the present invention
(1) 지방산 복합물에 옥수수 전분 및 이산화규소를 혼합한 후 절삭하여 지방산 복합 혼합물을 제조하는 단계;(1) preparing a fatty acid composite mixture by mixing corn starch and silicon dioxide with a fatty acid composite and then cutting;
(2) 대두에 열수를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하는 단계;(2) adding hot water to soybeans, grinding them, and homogenizing them to prepare ground soybeans;
(3) 차조기를 초임계 추출하여 차조기 초임계 추출물을 제조하는 단계;(3) supercritical extraction of perilla to prepare a supercritical extract of perilla;
(4) 상기 (1)단계의 제조한 지방산 복합 혼합물에 상기 (3)단계의 제조한 차조기 초임계 추출물을 첨가하여 용해시켜 지방산 복합물 용해액을 제조하는 단계; 및(4) preparing a fatty acid complex solution by adding and dissolving the perilla supercritical extract prepared in step (3) to the fatty acid complex mixture prepared in step (1); and
(5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 혼합한 후 멸균하고 균질화하는 단계를 포함하여 제조하는 것을 특징으로 하는 지방산 복합물 액상 식품의 제조방법을 제공한다.(5) Mixing the ground soybean product prepared in step (2) and the fatty acid complex solution prepared in step (4), sterilizing and homogenizing A fatty acid complex liquid food characterized in that it is prepared. A manufacturing method is provided.
본 발명의 지방산 복합물 액상 식품의 제조방법에서, 상기 (1)단계의 지방산 복합 혼합물은 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 65~75 중량부 및 이산화규소 0.5~1.5 중량부를 혼합한 후 절삭하여 제조할 수 있으며, 더욱 바람직하게는 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 69 중량부 및 이산화규소 1 중량부를 혼합한 후 절삭하여 제조할 수 있다. 상기와 같은 비율로 옥수수 전분 및 이산화규소를 첨가하는 것이 지방산 복합 혼합물을 뭉침 현상없이 용이하게 절삭할 수 있었다.In the method for producing a fatty acid complex liquid food of the present invention, the fatty acid complex mixture in step (1) is obtained by mixing 65 to 75 parts by weight of corn starch and 0.5 to 1.5 parts by weight of silicon dioxide based on 100 parts by weight of the fatty acid complex in the fatty acid complex. It can be prepared by cutting, more preferably, it can be prepared by cutting after mixing 69 parts by weight of corn starch and 1 part by weight of silicon dioxide based on 100 parts by weight of the fatty acid complex in the fatty acid complex. Adding cornstarch and silicon dioxide in the above ratios made it possible to easily cut the fatty acid complex mixture without agglomeration.
또한, 본 발명의 지방산 복합물 액상 식품의 제조방법에서, 상기 (2)단계의 대두 마쇄물은 바람직하게는 대두 0.8~1.2 kg에 80~90℃ 열수 1.5~2.5 L를 첨가하여 마쇄하고 균질화하여 제조할 수 있으며, 더욱 바람직하게는 대두 1 kg에 85℃ 열수 2 L를 첨가하여 마쇄하고 균질화하여 제조할 수 있다. 상기와 같은 조건으로 대두 마쇄물을 제조하는 것이 지방산 복합물과 잘 어우러지면서 고소한 맛과 부드러운 향이 증진된 대두 마쇄물로 제조할 수 있었다.In addition, in the method for producing a fatty acid complex liquid food of the present invention, the ground soybean product in step (2) is preferably prepared by adding 1.5 to 2.5 L of hot water at 80 to 90 ° C. to 0.8 to 1.2 kg of soybean, followed by grinding and homogenization It can be done, and more preferably, it can be prepared by adding 2 L of 85 ° C hot water to 1 kg of soybeans, grinding them, and homogenizing them. The production of ground soybean under the above conditions was able to produce ground soybean with improved savory taste and soft aroma while being well harmonized with the fatty acid complex.
또한, 본 발명의 지방산 복합물 액상 식품의 제조방법에서, 상기 (3)단계의 차조기 초임계 추출물은 바람직하게는 차조기를 초임계 이산화탄소를 용매로 사용하여 40~60℃의 온도 및 350~450 bar의 압력 조건에서 2~4시간 동안 추출하여 제조할 수 있으며, 더욱 바람직하게는 차조기를 초임계 이산화탄소를 용매로 사용하여 50℃의 온도 및 400 bar의 압력 조건에서 3시간 동안 추출하여 제조할 수 있다. 상기와 같은 조건으로 차조기를 추출하는 것이 유효성분을 다량 함유하면서 수율을 향상시킬 수 있었다.In addition, in the method for producing a fatty acid complex liquid food of the present invention, the perilla supercritical extract in step (3) is preferably perilla using supercritical carbon dioxide as a solvent at a temperature of 40 to 60 ° C. and 350 to 450 bar It can be prepared by extraction for 2 to 4 hours under pressure conditions, and more preferably, perilla can be prepared by extraction for 3 hours at a temperature of 50 ° C. and a pressure of 400 bar using supercritical carbon dioxide as a solvent. Extraction of perilla under the above conditions could improve the yield while containing a large amount of active ingredients.
또한, 본 발명의 지방산 복합물 액상 식품의 제조방법에서, 상기 (4)단계의 지방산 복합물 용해액은 바람직하게는 지방산 복합 혼합물 100 중량부에 차조기 초임계 추출물을 0.8~1.2 중량부 첨가하여 70~90℃에서 50~70분 동안 용해시켜 제조할 수 있으며, 더욱 바람직하게는 지방산 복합 혼합물 100 중량부에 차조기 초임계 추출물을 1 중량부 첨가하여 80℃에서 60분 동안 용해시켜 제조할 수 있다.In addition, in the method for producing a fatty acid complex liquid food of the present invention, the fatty acid complex solution in step (4) is preferably 70 to 90% by weight of 0.8 to 1.2 parts by weight of perilla supercritical extract added to 100 parts by weight of the fatty acid complex mixture. It can be prepared by dissolving at ° C. for 50 to 70 minutes, more preferably by adding 1 part by weight of perilla supercritical extract to 100 parts by weight of the fatty acid complex mixture and dissolving at 80 ° C. for 60 minutes.
또한, 본 발명의 지방산 복합물 액상 식품의 제조방법에서, 상기 (5)단계는 바람직하게는 대두 마쇄물과 지방산 복합물 용해액을 8.8~9.2:0.8~1.2 부피 비율로 혼합한 후 130~150℃에서 20~40초 동안 멸균하고 250~350 bar로 균질화할 수 있으며, 더욱 바람직하게는 대두 마쇄물과 지방산 복합물 용해액을 9:1 부피 비율로 혼합한 후 143℃에서 33초 동안 멸균하고 300 bar로 균질화할 수 있다.In addition, in the method for producing a fatty acid complex liquid food of the present invention, step (5) is preferably performed by mixing soybean ground material and fatty acid complex solution in a volume ratio of 8.8 to 9.2: 0.8 to 1.2 at 130 to 150 ° C. It can be sterilized for 20 to 40 seconds and homogenized at 250 to 350 bar. More preferably, after mixing soybean grounds and fatty acid complex solution in a volume ratio of 9: 1, sterilized at 143 ° C. for 33 seconds and 300 bar can be homogenized.
상기 (4) 및 (5)단계의 조건으로 재료들을 혼합하는 것이 맛과 풍미가 우수한 액상 식품으로 제조할 수 있었다.Mixing the ingredients under the conditions of steps (4) and (5) could produce a liquid food with excellent taste and flavor.
본 발명의 지방산 복합물 액상 식품의 제조방법은, 보다 구체적으로는The method for producing the fatty acid complex liquid food of the present invention is more specifically
(1) 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 65~75 중량부 및 이산화규소 0.5~1.5 중량부를 혼합한 후 절삭하여 지방산 복합 혼합물을 제조하는 단계;(1) preparing a fatty acid composite mixture by mixing 65 to 75 parts by weight of corn starch and 0.5 to 1.5 parts by weight of silicon dioxide based on 100 parts by weight of the fatty acid composite in a fatty acid composite and then cutting;
(2) 대두 0.8~1.2 kg에 80~90℃ 열수 1.5~2.5 L를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하는 단계;(2) adding 1.5 to 2.5 L of 80 to 90 ° C. hot water to 0.8 to 1.2 kg of soybeans, grinding and homogenizing to prepare ground soybeans;
(3) 차조기를 초임계 이산화탄소를 용매로 사용하여 40~60℃의 온도 및 350~450 bar의 압력 조건에서 2~4시간 동안 추출하여 차조기 초임계 추출물을 제조하는 단계;(3) preparing a perilla supercritical extract by extracting perilla using supercritical carbon dioxide as a solvent at a temperature of 40 to 60 ° C and a pressure of 350 to 450 bar for 2 to 4 hours;
(4) 상기 (1)단계의 제조한 지방산 복합 혼합물 100 중량부에 상기 (3)단계의 제조한 차조기 초임계 추출물을 0.8~1.2 중량부 첨가하여 70~90℃에서 50~70분 동안 용해시켜 지방산 복합물 용해액을 제조하는 단계; 및(4) 0.8 to 1.2 parts by weight of perilla supercritical extract prepared in step (3) was added to 100 parts by weight of the fatty acid complex mixture prepared in step (1) and dissolved at 70 to 90 ° C for 50 to 70 minutes. Preparing a fatty acid complex solution; and
(5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 8.8~9.2:0.8~1.2 부피 비율로 혼합한 후 130~150℃에서 20~40초 동안 멸균하고 250~350 bar로 균질화하는 단계를 포함할 수 있으며,(5) After mixing the ground soybean product prepared in step (2) and the fatty acid complex solution prepared in step (4) in a volume ratio of 8.8 to 9.2: 0.8 to 1.2, 20 to 40 seconds at 130 to 150 ° C. It may include sterilizing during and homogenizing at 250 to 350 bar,
더욱 구체적으로는more specifically
(1) 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 69 중량부 및 이산화규소 1 중량부를 혼합한 후 절삭하여 지방산 복합 혼합물을 제조하는 단계;(1) preparing a fatty acid composite mixture by mixing 69 parts by weight of corn starch and 1 part by weight of silicon dioxide based on 100 parts by weight of the fatty acid composite in a fatty acid composite, and then cutting;
(2) 대두 1 kg에 85℃ 열수 2 L를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하는 단계;(2) adding 2 L of 85 ° C. hot water to 1 kg of soybeans, grinding and homogenizing to prepare ground soybeans;
(3) 차조기를 초임계 이산화탄소를 용매로 사용하여 50℃의 온도 및 400 bar의 압력 조건에서 3시간 동안 추출하여 차조기 초임계 추출물을 제조하는 단계;(3) extracting perilla using supercritical carbon dioxide as a solvent at a temperature of 50° C. and a pressure of 400 bar for 3 hours to prepare a supercritical extract of perilla;
(4) 상기 (1)단계의 제조한 지방산 복합 혼합물 100 중량부에 상기 (3)단계의 제조한 차조기 초임계 추출물을 1 중량부 첨가하여 80℃에서 60분 동안 용해시켜 지방산 복합물 용해액을 제조하는 단계; 및(4) 1 part by weight of perilla supercritical extract prepared in step (3) was added to 100 parts by weight of the fatty acid complex mixture prepared in step (1) and dissolved at 80 ° C. for 60 minutes to prepare a fatty acid complex solution. doing; and
(5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 9:1 부피 비율로 혼합한 후 143℃에서 33초 동안 멸균하고 300 bar로 균질화하는 단계를 포함할 수 있다.(5) After mixing the soybean ground product prepared in step (2) and the fatty acid complex solution prepared in step (4) in a volume ratio of 9: 1, sterilized at 143 ° C. for 33 seconds and homogenized at 300 bar steps may be included.
본 발명은 또한, 상기 방법으로 제조된 지방산 복합물 액상 식품을 제공한다.The present invention also provides a fatty acid complex liquid food prepared by the above method.
본 발명은 또한, 상기 지방산 복합물 액상 식품을 함유하는 가공식품을 제공한다. 상기 가공식품의 종류에는 특별한 제한은 없다. 상기 지방산 복합물 액상 식품을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 떡류, 누룽지, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 가공식품을 모두 포함한다.The present invention also provides a processed food containing the fatty acid complex liquid food. There is no particular limitation on the type of the processed food. Examples of foods to which the fatty acid complex liquid food can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, chewing gum, rice cakes, scorched rice, dairy products including ice cream, and various soups , beverages, tea, drinks, alcoholic beverages and vitamin complexes, etc., and includes all processed foods in a conventional sense.
이하, 본 발명의 제조예 및 실시예를 들어 상세히 설명한다. 단, 하기 제조예 및 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 제조예 및 실시예에 한정되는 것은 아니다.Hereinafter, production examples and examples of the present invention will be described in detail. However, the following Preparation Examples and Examples are only to illustrate the present invention, and the content of the present invention is not limited to the following Preparation Examples and Examples.
제조예 1. 지방산 복합물(FAC)Preparation Example 1. Fatty acid complex (FAC)
식용 우지(牛脂)에 리파아제 및 정제수를 첨가하여 효소반응시키고 160~180℃의 열을 가하였다(가수분해 공정). 그 다음, 12시간 동안 정제한 후 60℃에서 5시간 동안 농축하여 우지 농축물을 제조하였다. 상기 제조한 우지 농축물을 세틸알코올(cetyl alcohol)을 1:1 부피 비율로 넣은 후 190~200℃의 열을 가하여 에스테르화 반응시켜 지방산 복합물을 제조하였다.Lipase and purified water were added to edible beef tallow to cause an enzymatic reaction, and heat was applied at 160 to 180 ° C (hydrolysis process). Then, after purifying for 12 hours, concentrated at 60 ℃ for 5 hours to prepare a tallow concentrate. A fatty acid complex was prepared by adding cetyl alcohol to the prepared beef tallow concentrate in a 1:1 volume ratio, followed by esterification by applying heat at 190 to 200 °C.
제조예 2. 지방산 복합물 액상 식품Production Example 2. Fatty acid complex liquid food
(1) 상기 제조예 1의 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 69 중량부 및 이산화규소 1 중량부를 혼합한 후 밀링기계에 넣어 절삭하여 분말 형태의 지방산 복합 혼합물을 제조하였다(도 1).(1) The fatty acid complex of Preparation Example 1 was mixed with 69 parts by weight of corn starch and 1 part by weight of silicon dioxide based on 100 parts by weight of the fatty acid complex, and then put in a milling machine and cut to prepare a fatty acid complex mixture in powder form (FIG. 1 ).
(2) 탈피한 대두 1 kg에 85℃ 열수 2 L를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하였다.(2) Ground soybean products were prepared by adding 2 L of 85° C. hot water to 1 kg of peeled soybeans, grinding them, and homogenizing them.
(3) 차조기를 초임계 이산화탄소를 용매로 사용하여 50℃의 온도 및 400 bar의 압력 조건에서 3시간 동안 추출하여 차조기 초임계 추출물을 제조하였다.(3) A perilla supercritical extract was prepared by extracting perilla using supercritical carbon dioxide as a solvent at a temperature of 50° C. and a pressure of 400 bar for 3 hours.
(4) 상기 (1)단계의 제조한 지방산 복합 혼합물 100 중량부에 상기 (3)단계의 제조한 차조기 초임계 추출물 1 중량부 첨가하여 80℃에서 1시간 동안 용해시켜 지방산 복합물 용해액을 제조하였다.(4) 1 part by weight of perilla supercritical extract prepared in step (3) was added to 100 parts by weight of the fatty acid complex mixture prepared in step (1) and dissolved at 80 ° C. for 1 hour to prepare a fatty acid complex solution. .
(5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 9:1 부피 비율로 혼합한 후 143℃에서 33초 동안 멸균하고 300 bar로 균질화시켰다.(5) The ground soybean product prepared in step (2) and the fatty acid complex solution prepared in step (4) were mixed in a volume ratio of 9: 1, sterilized at 143 ° C. for 33 seconds, and homogenized at 300 bar. .
비교예 1. 지방산 복합물 액상 식품Comparative Example 1. Fatty acid complex liquid food
(1) 상기 제조예 1의 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 69 중량부 및 이산화규소 1 중량부를 혼합한 후 밀링기계에 넣어 절삭하여 분말 형태의 지방산 복합 혼합물을 제조하였다.(1) The fatty acid composite of Preparation Example 1 was mixed with 69 parts by weight of corn starch and 1 part by weight of silicon dioxide based on 100 parts by weight of the fatty acid composite, and then put in a milling machine and cut to prepare a fatty acid composite mixture in powder form.
(2) 상기 (1)단계의 제조한 지방산 복합물 용해물에 정제수를 1:9 부피 비율로 혼합한 후 143℃에서 33초 동안 멸균하고 300 bar로 균질화시켰다.(2) Purified water was mixed with the fatty acid complex lysate prepared in step (1) at a volume ratio of 1:9, sterilized at 143° C. for 33 seconds, and homogenized at 300 bar.
비교예 2. 지방산 복합물 액상 식품Comparative Example 2. Fatty acid complex liquid food
(1) 상기 제조예 1의 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 69 중량부 및 이산화규소 1 중량부를 혼합한 후 밀링기계에 넣어 절삭하여 분말 형태의 지방산 복합 혼합물을 제조하였다.(1) The fatty acid composite of Preparation Example 1 was mixed with 69 parts by weight of corn starch and 1 part by weight of silicon dioxide based on 100 parts by weight of the fatty acid composite, and then put in a milling machine and cut to prepare a fatty acid composite mixture in powder form.
(2) 탈피한 대두 1 kg에 85℃ 열수 2 L를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하였다.(2) Ground soybean products were prepared by adding 2 L of 85° C. hot water to 1 kg of peeled soybeans, grinding them, and homogenizing them.
(3) 상기 (1)단계의 제조한 지방산 복합 혼합물을 80℃에서 1시간 동안 용해시켜 지방산 복합물 용해액을 제조하였다.(3) The fatty acid complex mixture prepared in step (1) was dissolved at 80 ° C. for 1 hour to prepare a fatty acid complex solution.
(4) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (3)단계의 제조한 지방산 복합물 용해액을 9:1 부피 비율로 혼합한 후 143℃에서 33초 동안 멸균하고 300 bar로 균질화시켰다.(4) The ground soybean product prepared in step (2) and the fatty acid complex solution prepared in step (3) were mixed in a volume ratio of 9: 1, sterilized at 143 ° C. for 33 seconds, and homogenized at 300 bar. .
비교예 3. 지방산 복합물 액상 식품Comparative Example 3. Fatty acid complex liquid food
(1) 상기 제조예 1의 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 69 중량부 및 이산화규소 1 중량부를 혼합한 후 밀링기계에 넣어 절삭하여 분말 형태의 지방산 복합 혼합물을 제조하였다(도 1).(1) The fatty acid complex of Preparation Example 1 was mixed with 69 parts by weight of corn starch and 1 part by weight of silicon dioxide based on 100 parts by weight of the fatty acid complex, and then put in a milling machine and cut to prepare a fatty acid complex mixture in powder form (FIG. 1 ).
(2) 차조기를 초임계 이산화탄소를 용매로 사용하여 50℃의 온도 및 400 bar의 압력 조건에서 3시간 동안 추출하여 차조기 초임계 추출물을 제조하였다.(2) Supercritical perilla extract was prepared by extracting perilla using supercritical carbon dioxide as a solvent at a temperature of 50° C. and a pressure of 400 bar for 3 hours.
(3) 상기 (1)단계의 제조한 지방산 복합 혼합물 100 중량부에 상기 (2)단계의 제조한 차조기 초임계 추출물 1 중량부 첨가하여 80℃에서 1시간 동안 용해시켜 지방산 복합물 용해액을 제조하였다.(3) 1 part by weight of perilla supercritical extract prepared in step (2) was added to 100 parts by weight of the fatty acid complex mixture prepared in step (1) and dissolved at 80 ° C. for 1 hour to prepare a fatty acid complex solution. .
(4) 상기 (3)단계의 제조한 지방산 복합물 용해액에 정제수를 1:9 부피 비율로 혼합한 후 143℃에서 33초 동안 멸균하고 300 bar로 균질화시켰다.(4) Purified water was mixed with the fatty acid complex solution prepared in step (3) at a volume ratio of 1:9, sterilized at 143° C. for 33 seconds, and homogenized at 300 bar.
실시예 1. 관능적 특성Example 1. Sensory Characteristics
관능검사는 관능검사 요원 총 80명을 대상으로 향, 맛, 질감 및 종합 기호도를 구분하여 1점 매우 나쁘다, 4점 나쁘다, 3점 보통이다, 4점 좋다, 5점 매우 좋음으로 나타나는 5점 기호척도법으로 3 반복한 후 평균을 계산하여 나타내었다.In the sensory test, a total of 80 sensory test agents were classified into aroma, taste, texture, and overall preference, and 1 point was very bad, 4 points was bad, 3 points were average, 4 points were good, and 5 points were very good. After 3 repetitions by the scaling method, the average was calculated and displayed.
그 결과, 비교예들에 비해 제조예 1의 지방산 복합물 액상 식품이 모든 항목에서 가장 높게 나와 평가자들에 의해 선호됨을 확인할 수 있었다.As a result, it was confirmed that the fatty acid complex liquid food of Preparation Example 1 was preferred by the evaluators as compared to the comparative examples, with the highest score in all items.
Claims (4)
(2) 대두에 열수를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하는 단계;
(3) 차조기를 초임계 추출하여 차조기 초임계 추출물을 제조하는 단계;
(4) 상기 (1)단계의 제조한 지방산 복합 혼합물에 상기 (3)단계의 제조한 차조기 초임계 추출물을 첨가하여 용해시켜 지방산 복합물 용해액을 제조하는 단계; 및
(5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 혼합한 후 멸균하고 균질화하는 단계를 포함하여 제조하는 것을 특징으로 하는 지방산 복합물 액상 식품의 제조방법.(1) preparing a fatty acid composite mixture by mixing corn starch and silicon dioxide with a fatty acid composite and then cutting;
(2) adding hot water to soybeans, grinding them, and homogenizing them to prepare ground soybeans;
(3) supercritical extraction of perilla to prepare a supercritical extract of perilla;
(4) preparing a fatty acid complex solution by adding and dissolving the perilla supercritical extract prepared in step (3) to the fatty acid complex mixture prepared in step (1); and
(5) Mixing the ground soybean product prepared in step (2) and the fatty acid complex solution prepared in step (4), sterilizing and homogenizing A fatty acid complex liquid food characterized in that it is prepared. manufacturing method.
(1) 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 65~75 중량부 및 이산화규소 0.5~1.5 중량부를 혼합한 후 절삭하여 지방산 복합 혼합물을 제조하는 단계;
(2) 대두 0.8~1.2 kg에 열수 1.5~2.5 L를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하는 단계;
(3) 차조기를 초임계 추출하여 차조기 초임계 추출물을 제조하는 단계;
(4) 상기 (1)단계의 제조한 지방산 복합 혼합물 100 중량부에 상기 (3)단계의 제조한 차조기 초임계 추출물을 0.8~1.2 중량부 첨가하여 용해시켜 지방산 복합물 용해액을 제조하는 단계; 및
(5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 8.8~9.2:0.8~1.2 부피 비율로 혼합한 후 멸균하고 균질화하는 단계를 포함하여 제조하는 것을 특징으로 하는 지방산 복합물 액상 식품의 제조방법.According to claim 1,
(1) preparing a fatty acid composite mixture by mixing 65 to 75 parts by weight of corn starch and 0.5 to 1.5 parts by weight of silicon dioxide based on 100 parts by weight of the fatty acid composite in a fatty acid composite and then cutting;
(2) adding 1.5 to 2.5 L of hot water to 0.8 to 1.2 kg of soybeans, grinding and homogenizing to prepare ground soybeans;
(3) supercritical extraction of perilla to prepare a supercritical extract of perilla;
(4) preparing a fatty acid complex solution by adding 0.8 to 1.2 parts by weight of perilla supercritical extract prepared in step (3) to 100 parts by weight of the fatty acid complex mixture prepared in step (1) and dissolving; and
(5) Mixing the soybean ground product prepared in step (2) and the fatty acid complex solution prepared in step (4) in a volume ratio of 8.8 to 9.2: 0.8 to 1.2, followed by sterilization and homogenization Method for producing a fatty acid complex liquid food, characterized in that.
(1) 지방산 복합물에 지방산 복합물 100 중량부 기준으로 옥수수 전분 65~75 중량부 및 이산화규소 0.5~1.5 중량부를 혼합한 후 절삭하여 지방산 복합 혼합물을 제조하는 단계;
(2) 대두 0.8~1.2 kg에 80~90℃ 열수 1.5~2.5 L를 첨가하여 마쇄하고 균질화하여 대두 마쇄물을 제조하는 단계;
(3) 차조기를 초임계 이산화탄소를 용매로 사용하여 40~60℃의 온도 및 350~450 bar의 압력 조건에서 2~4시간 동안 추출하여 차조기 초임계 추출물을 제조하는 단계;
(4) 상기 (1)단계의 제조한 지방산 복합 혼합물 100 중량부에 상기 (3)단계의 제조한 차조기 초임계 추출물을 0.8~1.2 중량부 첨가하여 70~90℃에서 50~70분 동안 용해시켜 지방산 복합물 용해액을 제조하는 단계; 및
(5) 상기 (2)단계의 제조한 대두 마쇄물과 상기 (4)단계의 제조한 지방산 복합물 용해액을 8.8~9.2:0.8~1.2 부피 비율로 혼합한 후 130~150℃에서 20~40초 동안 멸균하고 250~350 bar로 균질화하는 단계를 포함하여 제조하는 것을 특징으로 하는 지방산 복합물 액상 식품의 제조방법.According to claim 2,
(1) preparing a fatty acid composite mixture by mixing 65 to 75 parts by weight of corn starch and 0.5 to 1.5 parts by weight of silicon dioxide based on 100 parts by weight of the fatty acid composite in a fatty acid composite and then cutting;
(2) adding 1.5 to 2.5 L of 80 to 90 ° C. hot water to 0.8 to 1.2 kg of soybeans, grinding and homogenizing to prepare ground soybeans;
(3) preparing a perilla supercritical extract by extracting perilla using supercritical carbon dioxide as a solvent at a temperature of 40 to 60 ° C and a pressure of 350 to 450 bar for 2 to 4 hours;
(4) 0.8 to 1.2 parts by weight of perilla supercritical extract prepared in step (3) was added to 100 parts by weight of the fatty acid complex mixture prepared in step (1) and dissolved at 70 to 90 ° C for 50 to 70 minutes. Preparing a fatty acid complex solution; and
(5) After mixing the ground soybean product prepared in step (2) and the fatty acid complex solution prepared in step (4) in a volume ratio of 8.8 to 9.2: 0.8 to 1.2, 20 to 40 seconds at 130 to 150 ° C. Method for producing a fatty acid complex liquid food, characterized in that for manufacturing, including the step of sterilizing and homogenizing at 250 ~ 350 bar during.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210165031A KR20230077860A (en) | 2021-11-26 | 2021-11-26 | Food for special medical comprising fatty acid complex FAC |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210165031A KR20230077860A (en) | 2021-11-26 | 2021-11-26 | Food for special medical comprising fatty acid complex FAC |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230077860A true KR20230077860A (en) | 2023-06-02 |
Family
ID=86755929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210165031A KR20230077860A (en) | 2021-11-26 | 2021-11-26 | Food for special medical comprising fatty acid complex FAC |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230077860A (en) |
-
2021
- 2021-11-26 KR KR1020210165031A patent/KR20230077860A/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6377764B2 (en) | Method for producing broccoli with increased sulforaphane content and method for using broccoli produced by this method | |
EP1972200B1 (en) | Method for producing a fluid konjak material | |
CA2854281C (en) | A muscle atrophy inhibitor | |
KR20100107498A (en) | Chia seed composition | |
EP2047760A1 (en) | Oral composition enabling increased absorption of cryptoxanthin | |
JP4448266B2 (en) | Chillability improving agent and composition for improving cooling performance | |
CN1178700C (en) | Taste modifier | |
JP7388469B2 (en) | Taste improver | |
WO2006132042A1 (en) | Nutritional supplement powder and fat for food or medicine | |
JPWO2018186328A1 (en) | Taste improver | |
JP5013588B2 (en) | Blood lipid improver | |
JP2010166876A (en) | Fermented black turmeric and method for producing the same | |
KR20020076818A (en) | Method for manufacturing lacquer-containing food, and food produced from the same | |
KR20230077860A (en) | Food for special medical comprising fatty acid complex FAC | |
KR102410710B1 (en) | Method for manufacturing soy source steamed chicken | |
US20190231740A1 (en) | Blood flow-improving agent, royal jelly composition, and method for producing royal jelly composition | |
KR101420283B1 (en) | Sauce Composition and Method of Manufacturing thereof | |
JP4750167B2 (en) | Process for producing sugar-free dairy products | |
CN107156326A (en) | The method that butter cream is planted in Arabic gum compounding production | |
JP6812395B2 (en) | An emulsified composition having a milk flavor, a method for producing the same, and a method for improving the flavor of the emulsified composition having a milk flavor. | |
JPH03240464A (en) | Healthy food containing dioscorea japonica thumb extract | |
KR101632955B1 (en) | Preparation of functional pickled egg and powder without fish flavor | |
RU2728384C1 (en) | Jam from black nightshade berries with hazelnuts is proposed | |
KR101788854B1 (en) | Manufacturing method of fermented rice bran and sea tangle with the use of the solid-state fermentation | |
RU2721859C1 (en) | Sherbet with herbal additives and a method for production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right |